Commerce.com reaches for the poison pill

So, yeah, the board went full “not today”

Rezolve Ai called Commerce.com’s new rights plan a “desperate” move — which is corporate for: “We do not like your offer, and we brought a legal flamethrower.” Commerce.com (NASDAQ: CMRC) adopted a stockholder rights plan, better known as a poison pill, after enduring a prolonged equity collapse and what Rezolve described as no clear recovery plan.

Translation: deal talks just got messier

A poison pill makes it harder for an unwanted bidder to quietly accumulate shares and seize control. It doesn’t automatically kill a takeover, but it does add a giant speed bump, which is exactly the point if the board thinks the company is being lowballed.

For investors, the interesting bit is what this says about the stock’s setup:

• The board is signaling it wants more leverage in any negotiations
• Rezolve’s bid pressure may not be going away anytime soon
• CMRC shareholders could be in for more volatility while the tug-of-war plays out

Big picture

This is one of those classic Wall Street soap operas where everyone claims they’re protecting shareholder value while trying to grab the steering wheel. If you own CMRC, the next question is simple: does the board’s defense buy time for a better offer, or just delay the inevitable?